Free Webinar | Automation of Study Design and Delivery Lifecycle to Increase Efficiency
August 13, 2020 | 11:00 am-12:00 pm EDT
Join Appian as we sit down with GlaxoSmithKline and discuss automation of study design and delivery lifecycle for life sciences organizations, and how leveraging low code platform capabilities together with agile development methodology could enable rapid development of solutions for increased efficiency and effectiveness and readiness in pandemics like COVID-19.
We will discuss employing and perfecting the automation of complex processes that were previously heavily dependent on considerable manual work. We will review how to enable more efficient and collaborative processes with a high degree of automation leveraging agile delivery structured on a succession of two-week sprints focused on improving transparency of data and decisions to improve protocol design and predictable protocol delivery. We will focus on the most effective ways for tracking documentations, milestones, and other components of the study design and planning process.
Chibby Ebhogiaye, Business Optimization Owner, GlaxoSmithKline
Evi Cohen, Vice President, Global Life Sciences & Healthcare, Appian
Business Optimization Owner, GlaxoSmithKline
Chibby Ebhogiaye is a Product Leader owning the technology strategy across Clinical Planning for GSK with a focus on protocol optimization, study visualization, and intelligence across trial operations and site engagement. As a clinical technology innovation leader, Chibby has experience in developing and delivering effective solutions to optimize protocol development, site feasibility and selection, contract management and budget negotiation, as well as supporting teams to develop a positive culture around data and technology in industry. Chibby is passionate about driving innovation through the delivery of effective and efficient solutions to make a difference in the conduct of clinical trials.
Vice President, Global Life Sciences & Healthcare, Appian
Evi is an experienced pharmaceutical executive with extensive background in developing global business portfolios with emphasis on new products, technologies, and IP. He is a skilled innovation management professional with experience managing global business process transformations and cross-functional teams. As Vice President, Global Life Sciences and Healthcare at Appian, Evi is responsible for client success and continued steady growth in license revenues across all pharmaceutical and healthcare clients. Formerly VP Global Innovation at Catalent, he established global innovation and IP strategies. He held prior roles in Legal Affairs, R&D, QA, Regulatory Affairs and Project Management. He holds an MBA in Pharmaceutical Management, MS in Biotechnology, and a BS in Chemistry.